Evidence map›Paper›PMID 28115873›Full record

ReviewClinical epidemiology2017

Causal inference as an emerging statistical approach in neurology: an example for epilepsy in the elderly.

Lidia Mvr Moura, M Brandon Westover, David Kwasnik, Andrew J Cole, John Hsu

Abstract readReview
In one paragraph

Review in Clinical epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lidia Mvr MouraMassachusetts General Hospital, Department of Neurology, Epilepsy Service, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
M Brandon WestoverMassachusetts General Hospital, Department of Neurology, Epilepsy Service, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
David KwasnikMassachusetts General Hospital, Department of Neurology, Epilepsy Service, Boston, MA, USA.
Andrew J ColeMassachusetts General Hospital, Department of Neurology, Epilepsy Service, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
John HsuMassachusetts General Hospital, Mongan Institute, Boston, MA, USA; Harvard Medical School, Department of Medicine, Boston, MA, USA; Harvard Medical School, Department of Health Care Policy, Boston, MA, USA.

Funding

Tradeoffs in the Design of Public Long-Term Care BenefitsP01AG032952 · NIA · HARVARD MEDICAL SCHOOL · PI Bruce E. Landon · 2009 to 2026
$39.0M
Natural Experiment of Value-Based Incentives for Preventive ServicesR01HD075121 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI HSU, JOHN · 2012 to 2016
$3.3M
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI PatientsR01MH104560 · NIMH · MCLEAN HOSPITAL · PI HSU, JOHN, ONGUR, DOST · 2014 to 2017
$3.0M
Screening for Free: A Value-Based Insurance Design Natural ExperimentR01CA164023 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HSU, JOHN · 2012 to 2015
$2.4M
Quantitative Monitoring and Control of Sedation and Pain in the ICU EnvironmentK23NS090900 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2014 to 2018
$988k
NCI NIH HHS R01 CA164023NIA NIH HHS P01 AG032952NICHD NIH HHS R01 HD075121NIMH NIH HHS R01 MH104560NINDS NIH HHS K23 NS090900
6 · The paper itself

Abstract

The elderly population faces an increasing number of cases of chronic neurological conditions, such as epilepsy and Alzheimer's disease. Because the elderly with epilepsy are commonly excluded from randomized controlled clinical trials, there are few rigorous studies to guide clinical practice. When the elderly are eligible for trials, they either rarely participate or frequently have poor adherence to therapy, thus limiting both generalizability and validity. In contrast, large observational data sets are increasingly available, but are susceptible to bias when using common analytic approaches. Recent developments in causal inference-analytic approaches also introduce the possibility of emulating randomized controlled trials to yield valid estimates. We provide a practical example of the application of the principles of causal inference to a large observational data set of patients with epilepsy. This review also provides a framework for comparative-effectiveness research in chronic neurological conditions.

Indexed as

causal inferenceepidemiologyepilepsyneurostatistics

Identifiers

PMID28115873
PMCPMC5221551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.